MU School of Medicine

Home/Tag: MU School of Medicine

New imaging technique shows effectiveness of Cystic Fibrosis drug

April 15, 2017 by Deidra Ashley Talissa Altes, MD, Chair of the Department of Radiology at the MU School of Medicine. Hyperpolarized helium MRI could aid in development of improved therapies for lung diseases According to the Cystic Fibrosis Foundation, more than 30,000 Americans are living with the disorder. It currently has no cure, though a

Nanotechnology a ‘green’ approach to treating liver cancer

November 29, 2016 (Nanowerk News) According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year. Currently, the only cure for the disease is to surgically remove the cancerous part of the liver or transplant the entire organ. However, an international study led by University of Missouri

Researchers Identify Mechanism that Impairs Blood Flow with Aging

New findings could lead to treatments for age-related vascular disease September 8, 2015 With the world’s elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow.

Professor Awarded $2.2 Million Grant for Clear Blood Pressure Display

Goal is user-friendly information for better patient understanding Physicians receive lots of information about patients in a short amount of time, and sometimes that information is scattered, disorganized or difficult to comprehend. Now, a researcher at the University of Missouri School of Medicine has received funding to develop a simpler and clearer system to display

MU School of Medicine, CoxHealth, Mercy work together to address critical physician shortage

COLUMBIA, Mo. (July 9, 2015) — The University of Missouri, the MU School of Medicine, CoxHealth and Mercy health systems of Springfield today celebrated their partnership designed to address a critical shortage of physicians in the state and nation by breaking ground for the Patient-Centered Care Learning Center in Columbia. The groundbreaking ceremony was held

Key Component in Protein that Causes Cystic Fibrosis Identified

In a study recently published in PNAS, a National Academy of Sciences journal, a team of cystic fibrosis researchers led by Tzyh-Chang Hwang, PhD, demonstrate how they identified a key mechanism that could influence the behavior of the CFTR protein and flow of chloride ions in and out of cells through the protein. Chloride is

Cause of Regression in Individuals with Down Syndrome Identified

Individuals with regressive Down syndrome return to baseline functioning when treated for Catatonia Judith Miles found that Catatonia, a treatable disorder, may cause regression in patients with Down syndrome. May 12, 2015 By: Fran Webber COLUMBIA, Mo. – Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech

Potential New Painkiller Provides Longer Lasting Effects

Researchers led by George Kracke, PhD, have discovered a new compound that offers longer lasting painkilling effects, and shows promise as an alternative to current anesthetics. The new compound developed at MU, boronicaine, could potentially serve many of those same functions as an injectable or topical painkiller. Kracke is associate professor of anesthesiology and perioperative

A Quantum Leap in Gene Therapy of Duchenne Muscular Dystrophy

Jan. 15, 2013 By: Christian Basi,  Office of Research, University of Missouri Usually, results from a new study help scientists inch their way toward an answer whether they are battling a health problem or are on the verge of a technological breakthrough. Once in a while, those results give them a giant leap forward. In a

Another Muscular Dystrophy Mystery Solved; MU Scientists Inch Closer to a Therapy for Patients

Dec. 07, 2012     By: Christian Basi, Office of Research, University of Missouri COLUMBIA, Mo. — Approximately 250,000 people in the United States suffer from muscular dystrophy, which occurs when damaged muscle tissue is replaced with fibrous, bony or fatty tissue and loses function. Three years ago, University of Missouri scientists found a molecular compound that